The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.
Sheptulina A.F.
National Medical Research Center for Therapy and Preventive Medicine;
Russian University of Medicine
Bryk D.D.
National Medical Research Center for Therapy and Preventive Medicine
Tsoriev T.T.
National Medical Research Center for Therapy and Preventive Medicine
Yafarova A.A.
National Medical Research Center for Therapy and Preventive Medicine
Mamutova E.M.
National Medical Research Center for Therapy and Preventive Medicine
Drapkina O.M.
National Medical Research Center for Therapy and Preventive Medicine;
Russian University of Medicine
Clinical consequences of the sarcopenic obesity. Part 2. Cardiovascular diseases and osteoporosis
Journal: Russian Journal of Preventive Medicine. 2024;27(9): 60‑66
Views: 462
Downloaded: 31
To cite this article:
Sheptulina AF, Bryk DD, Tsoriev TT, Yafarova AA, Mamutova EM, Drapkina OM. Clinical consequences of the sarcopenic obesity. Part 2. Cardiovascular diseases and osteoporosis. Russian Journal of Preventive Medicine.
2024;27(9):60‑66. (In Russ.)
https://doi.org/10.17116/profmed20242709160
This literature review continues the paper, «Clinical consequences of sarcopenic obesity. Part 1. Non-alcoholic fatty liver disease, type 2 diabetes mellitus, chronic kidney disease» (Russian Journal of Preventive Medicine. 2024;27(8):114–120. (In Russ.). https://doi.org/10.17116/profmed202427081114), and describes the association of sarcopenic obesity with cardiovascular diseases and osteoporosis from the point of their prevalence in patients with sarcopenic obesity compared to obese patients without sarcopenia and/or the general population. The paper analyses possible pathophysiological mechanisms that cause the development of clinical consequences in sarcopenic obesity. Unlike primary or age-associated sarcopenia, which is more common in aged people, sarcopenic obesity (as a form of secondary sarcopenia) can develop at any age. Besides, the authors prove a higher prevalence of chronic non-infectious diseases in sarcopenic obesity and give reasons for unfavorable outcomes for patients. This evidences the need for active detection of sarcopenic obesity and additional examination of patients for timely detection of clinical consequences of this pathology. Such tactics can contribute to improving the health status of the working-age population and reducing costs related to providing medical care.
Authors:
Sheptulina A.F.
National Medical Research Center for Therapy and Preventive Medicine;
Russian University of Medicine
Bryk D.D.
National Medical Research Center for Therapy and Preventive Medicine
Tsoriev T.T.
National Medical Research Center for Therapy and Preventive Medicine
Yafarova A.A.
National Medical Research Center for Therapy and Preventive Medicine
Mamutova E.M.
National Medical Research Center for Therapy and Preventive Medicine
Drapkina O.M.
National Medical Research Center for Therapy and Preventive Medicine;
Russian University of Medicine
Received:
14.05.2024
Accepted:
24.05.2024
List of references:
Close metadata
Email Confirmation
An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.
Email Confirmation
Log in to the site using your account in one of the services
We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.